Table 4: Characteristics of different dosimetric approaches concerning acquisition timing and interpolation method.

InvestigatorTherapeutic nuclideAcquisition timingsInterpolation method

Esser et al. [4], Sandström et al. [5], Larsson et al. [9] 177Lu1, 4, 7 dMN

Hindorf et al. [25] 90YNot fixed, up to 19–48 h, 2–4 acquisitionsNot reported for kidneys

Baechler et al. [17] 90Y, 177Lu, 111In0.5, 4 h, 1, 2 dMN of last three points

Cremonesi et al. [3] 90Y, 177Lu1, 4 h, 1, 2, 3 dMN or BI

Garkavij et al. [7] 177Lu 1 h, 1, 4, 7 dTRexp